Glenmark signs a deal to market Cosmo Pharma's acne cream in Europe and South Africa

Glenmark Pharmaceuticals stated on Wednesday that its subsidiary has signed distribution and licensing agreements for Winlevi, which is used to treat acne, with Cosmo Pharmaceuticals NV.

 

Glenmark Specialty SA, a Glenmark Pharma subsidiary, will market and distribute Winlevi throughout Europe and South Africa, according to a stock exchange filing.

 

According to the agreements, Glenmark Speciality SA will get exclusive rights to commercialize Winlevi in 15 EU countries and South Africa from Cassiopeia, a subsidiary of Cosmo.

 

Glenmark received rights in 15 EU countries: Bulgaria, the Czech Republic, Denmark, Finland, France, Hungary, Iceland, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, and Sweden.

 

Cassiopeia will be responsible for Centralized Marketing Authorization (CMA) at the European Medicines Agency (EMA), while Glenmark will be responsible for product registration in South Africa and the United Kingdom.

 

Glenmark Pharmaceuticals, a listed company, said that Cosmo will be the only supplier of the medicine.

 

Cassiopea will receive a $5 million upfront payment, as well as double-digit regulatory and sales milestones and agreed-upon double-digit royalties on net sales.

 

The United States Food and Drug Administration (USFDA) has cleared Winlevi for the treatment of acne in patients aged 12 and up.

 

The market for acne in the EU is predicted to expand from $928.7 million in 2021 to $1,297 million in 2028. Acne affects more than 90% of persons aged 11 to 30 years in Europe, with a high prevalence among teens fueling the market's rise.

Top stories
Company

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM

Company

Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM

Company

RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions